Last reviewed · How we verify
NCT05876078
DORAYA-HF OUS Assessment of the Doraya Catheter for the Treatment of ADHF Patients With Insufficient Response to Diuretics
NA trial testing Doraya catheter in Acute Decompensated Heart Failure in 25 participants. Completed in 28 February 2026.
28 February 2026
Quick facts
| Lead sponsor | Revamp Medical Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 1 July 2024 |
| Primary completion | 28 February 2026 |
| Estimated completion | 28 February 2026 |
| Sites | 10 locations across Italy, Slovakia, Germany, Poland, Spain |
Drugs / interventions tested
- Doraya catheter
Conditions studied
- Acute Decompensated Heart Failure — all drugs for Acute Decompensated Heart Failure →
Sponsor
Revamp Medical Ltd.
Who can join
18 and older, any sex, with Acute Decompensated Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05876078
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Doraya catheter
Trials testing the same drug.
- NCT03234647 — First In Human Study of the Doraya Catheter for the Treatment of AHF Patients · NA · completed
Other recruiting trials for Acute Decompensated Heart Failure
Currently open trials in the same condition.
- NCT07372040 — Add-on Diuretics in Acute Decompensated Heart Failure · Phase 2 · recruiting
- NCT07199088 — Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Ac · NA · recruiting
- NCT03951467 — Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations · NA · recruiting
- NCT06556810 — IC14 for Treatment of Acute Decompensated Heart Failure · Phase 1, PHASE2 · active not recruiting
- NCT06714409 — Venous Ultrasound Guided Organ Decongestion in Patients Hospitalized with Acute Decompensated Heart Failure · NA · recruiting
Other Revamp Medical Ltd. trials
Trials by the same sponsor.
- NCT04877652 — DR REGISTRY: Prospective Observational Study of ADHF Patients With Insufficient Response to Diuretics · completed
- NCT03234647 — First In Human Study of the Doraya Catheter for the Treatment of AHF Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05876078 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Revamp Medical Ltd.
- Last refreshed: 9 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05876078.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing